The prognostic value of the combined neutrophil-to-lymphocyte ratio (NLR) and neutrophil-to-platelet ratio (NPR) in sepsis

Abstract Sepsis is a severe disease characterized by high mortality rates. Our aim was to develop an early prognostic indicator of adverse outcomes in sepsis, utilizing easily accessible routine blood tests. A retrospective analysis of sepsis patients from the MIMIC-IV database was conducted. We performed univariate and multivariate regression analyses to identify independent risk factors associated with in-hospital mortality within 28 days. Logistic regression was utilized to combine the neutrophil-to-lymphocyte ratio (NLR) and the neutrophil-to-platelet ratio (NPR) into a composite score, denoted as NLRNPR. We used ROC curves to compare the prognostic performance of the models and Kaplan–Meier survival curves to assess the 28 day survival rate. Subgroup analysis was performed to evaluate the applicability of NLRNPR in different subpopulations based on specific characteristics. This study included a total of 1263 sepsis patients, of whom 179 died within 28 days of hospitalization, while 1084 survived beyond 28 days. Multivariate regression analysis identified age, respiratory rate, neutrophil-to-lymphocyte ratio (NLR), neutrophil-to-platelet ratio (NPR), hypertension, and sequential organ failure assessment (SOFA) score as independent risk factors for 28 day mortality in septic patients (P < 0. 05). Additionally, in the prediction model based on blood cell-related parameters, the combined NLRNPR score exhibited the highest predictive value for 28 day mortality (AUC = 0. 6666), followed by NLR (AUC = 0. 6456) and NPR (AUC = 0. 6284). Importantly, the performance of the NLRNPR score was superior to that of the commonly used SOFA score (AUC = 0. 5613). Subgroup analysis showed that NLRNPR remained an independent risk factor for 28 day in-hospital mortality in the subgroups of age, respiratory rate, and SOFA, although not in the hypertension subgroup. The combined use of NLR and NPR from routine blood tests represents a readily available and reliable predictive marker for 28 day mortality in sepsis patients. These results imply that clinicians should prioritize patients with higher NLRNPR scores for closer monitoring to reduce mortality rates.